What does Champions Oncology, Inc. do?
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also…
What is Champions Oncology, Inc.'s P/E and P/B ratio?
Champions Oncology, Inc. has a P/E ratio of -68.0 and a P/B ratio of 17.02.
What is Champions Oncology, Inc.'s debt-to-equity ratio?
Champions Oncology, Inc. has a debt-to-equity ratio of 2.46.
How much does Champions Oncology, Inc. owe compared with what it owns?
Champions Oncology, Inc. owes $0.87 for every $1 it owns (balance sheet Jul 2026), which is high.
What is Champions Oncology, Inc.'s Positivity rank?
Champions Oncology, Inc. is ranked #6,043 of 6,774 companies globally and #3,415 of 4,000 in United States on PositoAI, with a Positivity Score of 11,172.
Does Champions Oncology, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Champions Oncology, Inc..
Where can I read the latest news about Champions Oncology, Inc.?
Recent headlines about Champions Oncology, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Champions Oncology, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Champions Oncology, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.